KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Assets (2016 - 2025)

Historic Assets for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $7.5 billion.

  • Charles River Laboratories International's Assets fell 612.24% to $7.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year decrease of 612.24%. This contributed to the annual value of $7.5 billion for FY2024, which is 813.49% down from last year.
  • Charles River Laboratories International's Assets amounted to $7.5 billion in Q3 2025, which was down 612.24% from $7.6 billion recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Assets high stood at $8.2 billion for Q4 2023, and its period low was $5.8 billion during Q1 2021.
  • Over the past 5 years, Charles River Laboratories International's median Assets value was $7.6 billion (recorded in 2025), while the average stood at $7.5 billion.
  • As far as peak fluctuations go, Charles River Laboratories International's Assets soared by 3539.19% in 2021, and later tumbled by 813.49% in 2024.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Assets stood at $7.0 billion in 2021, then increased by 8.24% to $7.6 billion in 2022, then increased by 7.79% to $8.2 billion in 2023, then dropped by 8.13% to $7.5 billion in 2024, then fell by 0.19% to $7.5 billion in 2025.
  • Its Assets was $7.5 billion in Q3 2025, compared to $7.6 billion in Q2 2025 and $7.6 billion in Q1 2025.